CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $1.48B, above the global median of $1.18B
- FinancialsAltman Z-Score 1.43: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.48BUSDvs all stocks (USD)
Revenue (TTM)
489.73MUSDvs all stocks (USD)
Profit Margin
-9.21%Beta
0.6060xvs all stocks
52-Week Change
-45.04%vs all stocks
Market Capitalization
1.48BUSDvs all stocks (USD)
Enterprise Value
1.79BUSDvs all stocks (USD)
Forward P/E
12.92xPrice to Sales (TTM)
3.10xPrice to Book (MRQ)
4.18xEnterprise to Revenue
3.66xEnterprise to EBITDA
-81.06xGross Margin
56.85%Profit Margin
-9.21%Operating Margin
-5.81%Return on Assets (TTM)
-2.59%Return on Equity (TTM)
-12.77%Revenue (TTM)
489.73MUSDvs all stocks (USD)
Revenue per Share (TTM)
4.63USDUpdated Sep 26, 2026Quarterly Revenue Growth
15.90%Gross Profit (TTM)
280.90MUSDvs all stocks (USD)
EBITDA (TTM)
-22.13MUSDvs all stocks (USD)
Net Income (TTM)
-45.11MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
15.87%Operating Cash Flow (TTM)
64.63MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
82.96MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
443.64MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
187.04MUSDFY2025 · Dec 31, 2025Gross Profit
256.60MUSDFY2025 · Dec 31, 2025Operating Income
-48.52MUSDvs all stocks (USD)
Pre-tax Income
-58.96MUSDFY2025 · Dec 31, 2025Income Tax Expense
-11.31MUSDFY2025 · Dec 31, 2025Net Income
-47.65MUSDFY2025 · Dec 31, 2025EBIT
-49.48MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-17.45MUSDFY2025 · Dec 31, 2025Research & Development
118.40MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
181.03MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
4.16MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
9.49MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.4600USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.4600USDFY2025 · Dec 31, 2025Basic Shares Outstanding
103.90MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
103.90MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-47.65MUSDFY2025 · Dec 31, 2025Operating Cash Flow
30.89MUSDFY2025 · Dec 31, 2025Free Cash Flow
29.35MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
63.46MUSDFY2025 · Dec 31, 2025Income Tax Paid
475.00KUSDFY2025 · Dec 31, 2025Interest Paid
5.94MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-47.65MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
26.91MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-11.79MUSDFY2025 · Dec 31, 2025Stock-based Compensation
76.19MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.10MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-11.28MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.58MUSDFY2025 · Dec 31, 2025Capital Expenditures
-1.54MUSDFY2025 · Dec 31, 2025Net Acquisitions
-375.50MUSDFY2025 · Dec 31, 2025Purchase of Investments
-45.21MUSDFY2025 · Dec 31, 2025Sale of Investments
31.80MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-390.45MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
335.51MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-45.00MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
15.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-35.78MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
269.74MUSDFY2025 · Dec 31, 2025Shares Outstanding
106.94MSharesUpdated Sep 26, 2026Float Shares
50.47MSharesUpdated Sep 26, 2026Shares Short
6.41MSharesUpdated Sep 26, 2026Short Ratio
5.13daysvs all stocks
Short % of Shares Outstanding
8.65%vs all stocks
% Held by Insiders
23.82%vs all stocks
% Held by Institutions
93.62%vs all stocks
Total Cash (MRQ)
80.95MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.7570USDUpdated Sep 26, 2026Total Debt (MRQ)
358.16MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.9875xCurrent Ratio (MRQ)
2.13xBook Value per Share (MRQ)
3.39USDUpdated Sep 26, 2026Total Assets
847.23MUSDvs all stocks (USD)
Total Current Assets
187.22MUSDFY2025 · Dec 31, 2025Total Liabilities
485.18MUSDFY2025 · Dec 31, 2025Total Non-current Assets
660.01MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
395.63MUSDFY2025 · Dec 31, 2025Total Current Liabilities
89.55MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
63.46MUSDFY2025 · Dec 31, 2025Other Short-term Investments
35.63MUSDFY2025 · Dec 31, 2025Accounts Receivable
44.14MUSDFY2025 · Dec 31, 2025Accounts Payable
5.84MUSDFY2025 · Dec 31, 2025Short-term Debt
1.58MUSDFY2025 · Dec 31, 2025Deferred Revenue
34.77MUSDFY2025 · Dec 31, 2025Long-term Debt
366.97MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
237.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
106.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-523.85MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
362.05MUSDvs all stocks (USD)
52-Week Low
13.69USDUpdated Sep 26, 202652-Week High
25.96USDUpdated Sep 26, 202652-Week Change
-45.04%vs all stocks
Beta
0.6060xvs all stocks
50-Day MA
19.05USDUpdated Sep 26, 2026200-Day MA
18.34USDUpdated Sep 26, 2026Avg 10-Day Volume
2.61MSharesUpdated Sep 26, 2026Avg 30-Day Volume
1.72MSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-0.4300USDUpdated Sep 26, 2026Other Income / Expense
-5.12MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Debt Financing Activity
More cash moved through borrowing and repaying than through the business itself, and most of its debt is long-term.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.57Profit Margin: -0.09
Financial Health
Altman Z-Score 1.43: grey zoneSignificant
Altman Z-Score: 1.43
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $1.48B, above the global median of $1.18BNotable
Market cap (USD): 1,475,799,324Global Median: 1,180,223,658.953
Levered free cash flow is $82.96M, above the global median of $18.73MNotable
Levered free cash flow (USD): 82,957,752Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Focus Technology Co. Ltd.
Tier 1InterfaceRecurring-Revenue Lock-InFlowAttention
Evercommerce Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Ireader Technology Co., Ltd.
Tier 1InterfaceRecurring-Revenue Lock-InAttentionFlow
Wealthfront Corporation
Tier 1InterfaceRecurring-Revenue Lock-InRiskFlow
Digital Turbine Inc.
Tier 1InterfaceRecurring-Revenue Lock-InAttentionFlow
Lightspeed Commerce Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Sprinklr Inc.
Tier 1InterfaceRecurring-Revenue Lock-InSenseMakingFlow
Porch Group Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
GoodRx Holdings, Inc. Class A Common Stock
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
PagerDuty Inc.
Tier 1InterfaceRecurring-Revenue Lock-InSenseMakingFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Spire Global Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ars Pharmaceuticals Inc
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
TriSalus Life Sciences Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated